Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease
Matthew Moll(Brigham and Women's Hospital), Peter J. Castaldi(Brigham and Women's Hospital), Sool Lee(University of North Carolina at Chapel Hill), Auyon Ghosh(SUNY Upstate Medical University), Jeong H. Yun, Edwin K. Silverman(Brigham and Women's Hospital), Ruth Tal‐Singer, Brian D. Hobbs(Brigham and Women's Hospital), Don D. Sin(University of British Columbia), Adel Boueiz(Brigham and Women's Hospital), Craig P. Hersh(Brigham and Women's Hospital), Zhonghui Xu(Sun Yat-sen University), Aabida Saferali(Brigham and Women's Hospital), Michael H. Cho(Brigham and Women's Hospital)
American Journal of Respiratory and Critical Care Medicine
November 5, 2021
Cited by 44
Related Papers
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|2010|3k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2010|986